{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:32:50Z","timestamp":1780468370473,"version":"3.54.1"},"reference-count":44,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,8,1]]},"abstract":"<jats:p>Abdominal obesity and hyperinsulinemia play a key role in the development of the polycystic ovary syndrome (PCOS). Dietary-induced weight loss and the administration of insulin-lowering drugs, such as metformin, are usually followed by improved hyperandrogenism and related clinical abnormalities. This study was carried out to evaluate the effects of combined hypocaloric diet and metformin on body weight, fat distribution, the glucose-insulin system, and hormones in a group of 20 obese PCOS women[ body mass index (BMI) &amp;gt; 28 kg\/m2] with the abdominal phenotype (waist to hip ratio &amp;gt;0.80), and an appropriate control group of 20 obese women who were comparable for age and pattern of body fat distribution but without PCOS. At baseline, we measured sex hormone, sex hormone-binding globulin (SHBG), and leptin blood concentrations and performed an oral glucose tolerance test and computerized tomography (CT) at the L4-L5 level, to measure sc adipose tissue area (SAT) and visceral adipose tissue area. All women were then given a low-calorie diet (1200\u20131400 kcal\/day) alone for one month, after which anthropometric parameters and CT scan were newly measured. While continuing dietary treatment, PCOS women and obese controls were subsequently placed, in a random order, on metformin (850 mg\/os, twice daily) (12 and 8, respectively) or placebo (8 and 12, respectively), according to a double-blind design, for the following 6 months. Blood tests and the CT scan were performed in each woman at the end of the study while they were still on treatment.<\/jats:p>\n               <jats:p>During the treatment period, 3 women of the control group (all treated with placebo) were excluded because of noncompliance; and 2 PCOS women, both treated with metformin, were also excluded because they became pregnant. Therefore, the women cohort available for final statistical analysis included 18 PCOS (10 treated with metformin and 8 with placebo) and 17 control women (8 treated with metformin and 9 with placebo).<\/jats:p>\n               <jats:p>The treatment was well tolerated. In the PCOS group, metformin therapy improved hirsutism and menstrual cycles significantly more than placebo. Baseline anthropometric and CT parameters were similar in all groups. Hypocaloric dieting for 1 month similarly reduced BMI values and the waist circumference in both PCOS and control groups, without any significant effect on CT scan parameters. In both PCOS and control women, however, metformin treatment reduced body weight and BMI significantly more than placebo. Changes in the waist-to-hip ratio values were similar in PCOS women and controls, regardless of pharmacological treatment. Metformin treatment significantly decreased SAT values in both PCOS and control groups, although only in the latter group were SAT changes significantly greater than those observed during the placebo treatment. On the contrary, visceral adipose tissue area values significantly decreased during metformin treatment in both PCOS and control groups, but only in the former was the effect of metformin treatment significantly higher than that of placebo.<\/jats:p>\n               <jats:p>Fasting insulin significantly decreased in both PCOS women and controls, regardless of treatment, whereas glucose-stimulated insulin significantly decreased only in PCOS women and controls treated with metformin. Neither metformin or placebo significantly modified the levels of LH, FSH, dehydroepiandrosterone sulphate, and progesterone in any group, whereas testosterone concentrations decreased only in PCOS women treated with metformin. SHBG concentrations remained unchanged in all PCOS women; whereas in the control group, they significantly increased after both metformin and placebo. Leptin levels decreased only during metformin treatment in both PCOS and control groups.<\/jats:p>\n               <jats:p>In summary, this study shows that, in PCOS women with abdominal obesity, long-term treatment with metformin added to hypocaloric diet induced, in comparison with placebo, a greater reduction of body weight and abdominal fat, particularly the visceral depots, and a more consistent decrease of serum insulin, testosterone, and leptin concentrations. These changes were associated with a more significant improvement of hirsutism and menses abnormalities. Moreover, the effects on body weight, insulin, and leptin were similar to those observed in the group of comparable abdominally obese controls, in whom, however, a more pronounced reduction of sc fat in the abdominal region and an increase of SHBG concentrations were found. These findings, therefore, indicate that hyperinsulinemia and abdominal obesity may have complementary effects in the pathogenesis of PCOS.<\/jats:p>","DOI":"10.1210\/jcem.85.8.6738","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:05:46Z","timestamp":1389200746000},"page":"2767-2774","source":"Crossref","is-referenced-by-count":395,"title":["Effect of Long-Term Treatment with Metformin Added to Hypocaloric Diet on Body Composition, Fat Distribution, and Androgen and Insulin Levels in Abdominally Obese Women with and without the Polycystic Ovary Syndrome"],"prefix":"10.1210","volume":"85","author":[{"given":"Renato","family":"Pasquali","sequence":"first","affiliation":[{"name":"Endocrine Unit (R.P., A.G., D.B., V.V., L.G., D.C., S.F., A.M.M.-L.), Department of Internal Medicine and Gastroenterology, S. Orsola-Malpighi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Gambineri","sequence":"additional","affiliation":[{"name":"Endocrine Unit (R.P., A.G., D.B., V.V., L.G., D.C., S.F., A.M.M.-L.), Department of Internal Medicine and Gastroenterology, S. Orsola-Malpighi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Biscotti","sequence":"additional","affiliation":[{"name":"Endocrine Unit (R.P., A.G., D.B., V.V., L.G., D.C., S.F., A.M.M.-L.), Department of Internal Medicine and Gastroenterology, S. Orsola-Malpighi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Vicennati","sequence":"additional","affiliation":[{"name":"Endocrine Unit (R.P., A.G., D.B., V.V., L.G., D.C., S.F., A.M.M.-L.), Department of Internal Medicine and Gastroenterology, S. Orsola-Malpighi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Gagliardi","sequence":"additional","affiliation":[{"name":"Endocrine Unit (R.P., A.G., D.B., V.V., L.G., D.C., S.F., A.M.M.-L.), Department of Internal Medicine and Gastroenterology, S. Orsola-Malpighi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Colitta","sequence":"additional","affiliation":[{"name":"Endocrine Unit (R.P., A.G., D.B., V.V., L.G., D.C., S.F., A.M.M.-L.), Department of Internal Medicine and Gastroenterology, S. Orsola-Malpighi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Fiorini","sequence":"additional","affiliation":[{"name":"Endocrine Unit (R.P., A.G., D.B., V.V., L.G., D.C., S.F., A.M.M.-L.), Department of Internal Medicine and Gastroenterology, S. Orsola-Malpighi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela Estela","family":"Cognigni","sequence":"additional","affiliation":[{"name":"Department of Obstetric and Gynecology, Reproductive Endocrinology Center (G.E.C., M.F.), University of Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Filicori","sequence":"additional","affiliation":[{"name":"Department of Obstetric and Gynecology, Reproductive Endocrinology Center (G.E.C., M.F.), University of Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Maria","family":"Morselli-Labate","sequence":"additional","affiliation":[{"name":"Endocrine Unit (R.P., A.G., D.B., V.V., L.G., D.C., S.F., A.M.M.-L.), Department of Internal Medicine and Gastroenterology, S. Orsola-Malpighi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071618164930100_R1","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.","volume":"18","year":"1997","journal-title":"Endocr Rev"},{"key":"2020071618164930100_R2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.1993.tb01744.x","article-title":"The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women.","volume":"39","author":"Pasquali","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071618164930100_R3","first-page":"221","article-title":"Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome.","volume":"10","year":"1996","journal-title":"Clin Endocrinol Metab NA"},{"key":"2020071618164930100_R4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome.","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"2020071618164930100_R5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/edrv-12-1-3","article-title":"On the paradox of insulin-induced hyperandrogenism in insulin-resistant state.","volume":"12","year":"1991","journal-title":"Endocr Rev"},{"key":"2020071618164930100_R6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decrease of ovarian cytochrome P45017\u03b1 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"2020071618164930100_R7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1210\/jcem-57-3-645","article-title":"Sex hormone-binding globulin changes with androgen replacement.","volume":"57","author":"Plymate","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1210\/jcem-67-3-460","article-title":"Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin.","volume":"67","author":"Plymate","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0022-4731(89)90272-0","article-title":"On the regulation of sex-hormone-binding globulin: challenge of an old dogma and outlines of an alternative mechanism.","volume":"32","author":"Von Schultz","year":"1989","journal-title":"J Steroid Biochem"},{"key":"2020071618164930100_R10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/dmr.5610050202","article-title":"Biology of regional body fat distribution: relationship to non-insulin dependent diabetes mellitus.","volume":"5","author":"Kissebah","year":"1988","journal-title":"Diabetes Metab Rev"},{"key":"2020071618164930100_R11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1210\/jcem-57-2-304","article-title":"Relationship of androgenic activity to body fat topography, fat cell morphology and metabolic aberrations in premenopausal women.","volume":"57","author":"Evans","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-2007-1004907","article-title":"Characterization of obese women with reduced sex hormone-binding globulin concentrations.","volume":"22","author":"Pasquali","year":"1990","journal-title":"Horm Metab Res"},{"key":"2020071618164930100_R13","first-page":"1515","article-title":"Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy.","volume":"78","author":"Leenen","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/0026-0495(94)90118-X","article-title":"Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome.","volume":"43","author":"Pasquali","year":"1994","journal-title":"Metabolism"},{"key":"2020071618164930100_R15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2796.1993.tb01016.x","article-title":"Hyperandrogenicity in women-a prediabetic condition?","volume":"234","year":"1993","journal-title":"J Intern Med"},{"key":"2020071618164930100_R16","first-page":"2198","article-title":"Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women-a clinical research center study.","volume":"81","author":"Lovejoy","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-68-1-173","article-title":"Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss.","volume":"68","author":"Pasquali","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071618164930100_R19","first-page":"556","article-title":"17\u03b1-hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome after dietary weight loss.","volume":"82","author":"Jakubowicz","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R20","first-page":"524","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R21","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jcem-68-6-1027","article-title":"Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.","volume":"68","author":"Nestler","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"2020071618164930100_R23","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R24","first-page":"3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R25","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","article-title":"Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome.","volume":"340","author":"Nestler","year":"1999","journal-title":"N Engl J Med"},{"key":"2020071618164930100_R26","article-title":"Preventing and managing the global epidemic","year":"1997"},{"key":"2020071618164930100_R27","first-page":"3346","article-title":"Nitrendipine treatment in women with polycystic ovarian syndrome: evidence for a lack of effects of calcium channel blockers on insulin, androgens, and sex hormone-binding globulin.","volume":"80","author":"Pasquali","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0015-0282(16)48552-3","article-title":"Ultrasonic findings in polycystic ovarian diseasae.","volume":"43","author":"Orsini","year":"1985","journal-title":"Fertil Steril"},{"key":"2020071618164930100_R29","article-title":"Measuring obesity-classification and description of anthropometric data","year":"1988"},{"key":"2020071618164930100_R30","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0026-0495(98)90356-0","article-title":"Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels.","volume":"47","author":"Vicennati","year":"1998","journal-title":"Metabolism"},{"key":"2020071618164930100_R31","first-page":"187","article-title":"Techniques for the measurement of visceral fat: a practical guide.","volume":"17","author":"Koy","year":"1993","journal-title":"Int J Obes"},{"key":"2020071618164930100_R32","article-title":"Obesity and related diseases","author":"Garrow","year":"1988"},{"key":"2020071618164930100_R33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2265.1999.00701.x","article-title":"The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.","volume":"50","author":"Pasquali","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071618164930100_R34","article-title":"Non-parametric statistics of the behavioral sciences","author":"Siegel","year":"1956"},{"key":"2020071618164930100_R35","article-title":"Robust test for equality of variance. In: Olkin I, ed","author":"Levene","year":"1960"},{"key":"2020071618164930100_R36","article-title":"SPSS\/PC+ 4.0 base and advanced statistics manuals","author":"Norusis","year":"1990"},{"key":"2020071618164930100_R37","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1210\/jcem-73-4-691","article-title":"Insulin resistance in obese and nonobese man.","volume":"73","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R38","first-page":"2057","article-title":"Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.","volume":"80","author":"Crave","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R39","article-title":"Treatment of obesity: conventional programs and fat diets. In: Bjorntorp P, Brodoff BN, eds","author":"Dwyer","year":"1992"},{"key":"2020071618164930100_R40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000182732","article-title":"Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism.","volume":"39","author":"Pasquali","year":"1993","journal-title":"Horm Res"},{"key":"2020071618164930100_R41","first-page":"2586","article-title":"Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.","volume":"80","author":"Holte","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans.","volume":"334","author":"Considine","year":"1996","journal-title":"N Engl J Med"},{"key":"2020071618164930100_R43","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1210\/jcem.83.7.4944","article-title":"Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome.","volume":"83","author":"Morin-Papunen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618164930100_R44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s001250051210","article-title":"Nutritional regulation of leptin in humans.","volume":"42","author":"Coleman","year":"1999","journal-title":"Diabetologia"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/8\/2767\/9178270\/jcem2767.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/8\/2767\/9178270\/jcem2767.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:50:28Z","timestamp":1594957828000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/85\/8\/2767\/2852497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,1]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.85.8.6738","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8,1]]}}}